$EMBK .065 News Embark Holdings Inc. Acquires Muscle

New Post Public Reply Private Reply Replies (1) Message Board
jstops

[b]$EMBK[/b] .065 News Embark Holdings Inc. Acquires Muscle Warfare, Inc. as a Wholly Owned Subsidiary


MISSION VIEJO, California, April 11, 2013 /PRNewswire via COMTEX/ -- Embark Holdings, Inc. (OTC: EMBK) a leader in providing research, evaluation and acquisition services to businesses throughout the world, announced acquiring 100% of Muscle Warfare, Inc. (http://musclewarfare.com) a company that develops, manufactures, and markets sports nutrition products of the highest quality for athletes around the world in all sports, including both professional and amateur enthusiasts. The acquisition consisted of preferred shares in Embark Holdings, Inc.

Muscle Warfare products are certified banned substance free by the World Anti-Doping Agency ("WADA") standards and are tested in one of the most elite testing labs in the world called HFL Sport Science, the world's largest and most experienced sports test laboratory. The HFL laboratory is ISO Certified and accredited for forensic testing and meets or exceeds world anti-doping agency standards and requirements. The company's processes insure that the product offerings distributed are free of inadvertent contaminants and are not deliberately spiked with contaminant compounds by many raw material manufacturers. Additionally, all Muscle Warfare products are manufactured in facilities that are NSF International "third party audited" and certified to meet or exceed, Good Manufacturing Practice ("GMP") guidelines. GMP quality assurance also insures all raw materials used in our products 'meet spec' and are what they claim to be.


Since 2008 Muscle Warfare, Inc. has been led by Mr. Daniel Amato. For the past 13 years he has been recognized as a proven winner within the industry with many successes and proven track record marketing and branding sports nutrition products through multiple brands and marketing strategies.


Muscle Warfare has reached approximately $1.9 million in sales in 2011, however, in 2012. Muscle Warfare performed a calculated pull back of sales distribution to successfully navigate an industry wide FDA notice on the ingredient DMAA, which restricted sales industry wide. "We expected to hit 3-4 Million in sales in 2012 with strong profits. Instead, we decided to utilize this time to carefully rebrand our products to be banned substance free and create formulations that were even more effective. During this process we had intentionally slowed sales to rebrand the company, upgrade our look and presentation and take our overall quality standards to the highest level," said Mr. Amato.


Muscle Warfare is pleased with this strategy as it has worked; we are now distributing product in approximately 550+ Vitamin Shoppe stores Nationwide. Also, they have a very strong partnership with Europa, the largest independent sports nutrition distributor in the U.S.; along with many Large scale International Clients, which we believe will help continue our growth trajectory.


Year-Ended 2011 Year-Ended 2012


Net Sales $1,902,583.00 $1,613,232.00


COGS $1,044,125.00 $966,391.00


Operating Expenses $1,039,661.00 $1,171,105.00


Net Income ($181,203.00) ($ 524,264.00)


The Sports Nutrition Market is among the fastest growing and was one of the most resilient markets since the 2007 market downturn, experiencing impressive growth during this entire period. This strong and rapid market growth is forecasted by experts to continue for years to come due to continued and growing use and promotion of these products by elite professional athletes and bodybuilders. In addition, the amateur athlete market continues to expand and grow which is increasing the use of these products; this segment is expected to exceed $6 billion by 2018 according to the most recent Consumer Trend Reports.


Daniel Amato, President and CEO of Embark Holdings, Inc. and Muscle Warfare, Inc. stated "I am very excited about the future of both companies and will keep the public informed of the progress. In addition, I would like to inform our shareholders that we have recently subscribed to OTCIQ and within a few weeks plan to be current with OTC Markets and continue to file reports on a quarterly basis, this is a very exciting time for the company and only the beginning of what I believe will be another success story."


About Muscle Warfare, Inc.


Muscle Warfare is a cutting edge sports nutrition manufacturer that is passionately driven to create and distribute the absolute highest quality products in the marketplace. Every product we develop has been forged with great experience and focus on maximizing product efficacy for real world results. Furthermore, Muscle Warfare products are rigorously tested by top testing labs to help insure them free of banned substances. We are truly committed to helping all athletes achieve and surpass their highest goals and potential.


For more information on Muscle Warfare see them at their website: http://musclewarfare.com/home/


About Vitamin Shoppe, Inc. (VSI)


Vitamin Shoppe is a leading multi-channel specialty retailer of nutritional products based in North Bergen, New Jersey. In its stores and on its website, the company carries one of the most comprehensive retail assortments in the industry, including vitamins, minerals, specialty supplements, herbs, sports nutrition, homeopathic remedies, green living products, and health and beauty aids. In addition to offering 400 national brand products, the Vitamin Shoppe also exclusively carries products under The Vitamin Shoppe, BodyTech, True Athlete and MyTrition brands. The Vitamin Shoppe conducts business through more than 600 company-operated retail stores under The Vitamin Shoppe, Super Supplements and Vitapath retail banners, and through its website, http://www.VitaminShoppe.com. Follow The Vitamin Shoppe on Facebook at http://www.facebook.com/THEVITAMINSHOPPE and on Twitter at http://twitter.com/VitaminShoppe


About Embark Holdings, Inc. (OTC: EMBK)


Founded in 1985 and headquartered in Mission Viejo, California, United States, our business model is to research, evaluate, and acquire profitable private firms in the business segments of entertainment, technology, medical, energy, and business services for the benefit of our shareholders.


By providing the financial and human capital necessary to deal with the overwhelming administrative, planning, governance, compliance, and regulatory issues that abound, our partners can focus their energy and flourish.


Stay up-to-date with current events by joining Embark Holdings, Inc. E-Mail Alert List. Join by going to the following: investors@embarkholdings.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 41

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 37

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 36

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 32

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

DCHFA Appoints Dr. Moreiça Allana-Kim Ortega for Strategic Leadership

Updated Category News Views 325

DCHFA Welcomes Dr. Moreiça Allana-Kim Ortega The District of Columbia Housing Finance Agency (DCHFA) has announced an exciting new direction by creating an Office of Strategic Planning and Performance, under the leadership of Dr. Moreiça Allana-Kim Ortega. This new office is aimed at enhancing the effectiveness of the agency by addressing the evolving needs of housing...

Continue Reading
Cboe Hits Milestone of 1,000 ETFs, Showcasing Growth Trend

Updated Category News Views 120

Cboe Achieves Major Milestone in ETF Listings Cboe Global Markets, Inc. (Cboe: CBOE) has achieved a remarkable feat by surpassing 1,000 U.S.-listed exchange-traded funds (ETFs). This notable accomplishment underscores Cboe's position as a premier venue for innovative actively-managed ETFs. The exchange has welcomed an impressive number of 185 new U.S. ETFs this year,...

Continue Reading
Eat Happy Kitchen Expands Reach with Nationwide Kroger Partnership

Updated Category News Views 1256

Eat Happy Kitchen Expands Retail Presence Nationally In an exciting development for health-conscious shoppers, Eat Happy Kitchen has significantly expanded its reach across the U.S. Nearly 500 stores under the Kroger family umbrella will now feature the woman-owned brand's all-natural line of pasta sauces. This rapid expansion is a testament to the growing demand for...

Continue Reading
ThreeD Capital Reveals December Net Asset Value of $0.76

Updated Category News Views 183

Understanding ThreeD Capital's Recent NAV Announcement ThreeD Capital Inc. is a venture capital firm that carefully evaluates its financial standing to provide clarity to its stakeholders. Recently, the company disclosed that its unaudited net asset value (NAV) per share was valued at $0.76 as of December 31, 2024. This announcement reflects ThreeD’s commitment to...

Continue Reading
Innovative Wealth Planning Tool by Simon Quick Advisors Unveiled

Updated Category News Views 112

Simon Quick Advisors Introduces WealthMetrx™ for Tax Efficiency Simon Quick Advisors, a leading independent wealth management firm, has unveiled a new service called WealthMetrx™. This innovative approach aims to offer clients a comprehensive understanding of their tax profile by transforming intricate data into practical insights. With WealthMetrx™, clients can...

Continue Reading